Exploring recent trials and updates in nonmelanoma skin cancer treatment.
This is a video synopsis/summary of a Peer Exchange involving Jason Luke, MD, FACP; Christopher Barker, MD; Omid Hamid, MD; Vishal Patel, MD; and Catherine Pisano, MD.
Hamid highlighted numerous studies beyond PD-1 inhibition under exploration for advanced basal cell carcinoma and cutaneous squamous cell carcinoma, including combination immunotherapies, immunomodulators targeting the tumor microenvironment, oncolytic viruses delivering immune stimulants, and radiation-immunotherapy sequencing. He advised referring immunotherapy-refractory patients to early-phase trials given the breadth of promising approaches. Luke likened the high response rates but common immunotherapy failure in advanced skin cancers to historical melanoma outcomes that fueled robust trial participation. However, continuous carcinoma patients lack this expectation and support. Hamid noted patient advocacy is integral to driving awareness and multidisciplinary coordination compared to melanoma. Pisano cited fledgling efforts at community engagement and patient groups to elevate disease seriousness beyond the dismissive “just freeze it off” perception. She looks forward to emerging immunotherapy data in solid-organ transplant recipients. Barker expects rapid expansion of combination strategies leveraging radiation, surgery, and diverse immunotherapy agents over the next few years to build on the initial success of single-agent PD-1 blockade.
Video synopsis is AI-generated and reviewed by AJMC® editorial staff.
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More